Iftikhar Pulwasha M, Shaheen Nighat, Arora Ena
Obstetrics and Gynecology, St. John's University, New York, USA.
Obstetrics and Gynecology, Cantonment General Hospital, Rawalpindi, PAK.
Cureus. 2019 Sep 13;11(9):e5646. doi: 10.7759/cureus.5646.
Background Postpartum intrauterine contraceptive device (PPIUCD) reduces the rate of abortions and it is a cost-effective, reversible, and convenient choice of contraception. The objective of our study was to evaluate the efficacy and satisfaction rate in women with postpartum intrauterine contraceptive device insertion. Methods This prospective study of immediate PPIUCD insertion was conducted at our institute from March 2016 to February 2019. Approval from the Institutional Review Board (IRB) was taken before starting the study. A total of 372 women were enrolled in the study after taking informed consent. All the women were counseled regarding different methods of contraception and birth control during antenatal checkups, early labor and immediately postpartum (within 48 hours). All the enrolled women in the study were followed for three years to determine the satisfaction and success rate of PPIUCD continuation. We also kept the record of women who discontinued PPIUCD. Results After the exclusion criteria, 372 women were recruited in the study. The mean gestation age at the time of delivery was 38.5 weeks with a standard deviation (SD) of 1.45. All the women were followed for short-term and long-term complications and satisfaction rates. Out of 372, 51.07% of women (n = 190) had a spontaneous vaginal delivery, and 48.9% of women (n = 182) had a cesarean section but there was no significant long-term satisfaction outcome difference in both the groups. The highest success rate of the postpartum long-acting intrauterine contraceptive device was noted in patients who were counseled thoroughly in the antenatal and intrapartum period 61.5% as compared to those patients who were counseled either antenatally 42.2 %, intrapartum 35.4%, or immediate postpartum 22.4% alone. Conclusion PPIUCD insertion is an opportunity not to be missed. It allows women to obtain safe, long-acting, highly effective contraception while already within the medical system. More research data are needed in the literature with regard to counseling timings for PPIUCD insertion during the antenatal and postnatal period as it can affect the decision of women to prevent unplanned pregnancy. PPIUCD has one of the highest patient satisfaction rates among all the contraceptives.
产后宫内节育器(PPIUCD)可降低流产率,是一种经济高效、可逆且方便的避孕选择。我们研究的目的是评估产后放置宫内节育器的有效性和满意度。方法:这项关于立即放置PPIUCD的前瞻性研究于2016年3月至2019年2月在我们研究所进行。在开始研究前获得了机构审查委员会(IRB)的批准。在获得知情同意后,共有372名女性纳入研究。在产前检查、分娩早期和产后立即(48小时内),对所有女性进行了关于不同避孕和节育方法的咨询。对研究中所有纳入的女性进行了三年的随访,以确定PPIUCD持续使用的满意度和成功率。我们还记录了停用PPIUCD的女性情况。结果:经过排除标准后,372名女性被纳入研究。分娩时的平均孕周为38.5周,标准差(SD)为1.45。对所有女性进行了短期和长期并发症及满意度的随访。在372名女性中,51.07%(n = 190)的女性经阴道自然分娩,48.9%(n = 182)的女性行剖宫产,但两组在长期满意度结果上无显著差异。与仅在产前咨询的患者(42.2%)、产时咨询的患者(35.4%)或产后立即咨询的患者(22.4%)相比,在产前和产时均接受充分咨询的患者中,产后长效宫内节育器的成功率最高,为61.5%。结论:放置PPIUCD是一个不容错过的机会。它使女性在已处于医疗系统内时就能获得安全、长效、高效的避孕方法。关于产前和产后放置PPIUCD的咨询时机,文献中还需要更多的研究数据,因为这会影响女性预防意外怀孕的决定。PPIUCD在所有避孕方法中患者满意度最高。